Circ Cardiovasc Qual Outcomes:2型糖尿病:超过四分之三低HbA1C患者治疗强度无降低!

2017-07-03 何娜 环球医学威廉亚洲官网

2型糖尿病占糖尿病患者90%以上,多在35~40岁之后发病。尚不清楚美国2型糖尿病患者治疗强度降低是否受到血糖控制、健康状况和历年的影响。2017年4月,发表在《Circ Cardiovasc Qual Outcomes.》的一项研究对此进行分析。结果表明,在虚弱的患者或有多种合并症患者中,超过四分之三的低HbA1C患者的血糖治疗强度没有降低。

2型糖尿病糖尿病患者90%以上,多在35~40岁之后发病。尚不清楚美国2型糖尿病患者治疗强度降低是否受到血糖控制、健康状况和历年的影响。2017年4月,发表在《Circ Cardiovasc Qual Outcomes.》的一项研究对此进行分析。结果表明,在虚弱的患者或有多种合并症患者中,超过四分之三的低HbA1C患者的血糖治疗强度没有降低。

背景:尚不清楚美国2型糖尿病患者治疗强度降低是否受到血糖控制、健康状况和历年(2008年2月前后,[糖尿病患者心血管风险控制行动]ACCORD试验中报告了强化血糖控制的安全问题)的影响。

方法和结果:研究者将强度降低定义为糖化血红蛋白(HbA1C)指标测量120天后中断至少1种降糖药物或降低至少1种降糖药物的剂量,而不添加其他药物或增加其他药物的剂量。在该项纳入99694例(平均年龄54岁)积极治疗新发糖尿病个体的回顾性队列研究(50%的患者使用1种药物,33%的患者使用2种药物,17%的患者使用≥3种药物)中,12921(13.0%)例患者1年后的HbA1C<6%,19670(19.7%)例患者的HbA1C水平在6.0%~6.4%,35012(35.1%)例患者的HbA1C水平在6.5%~7.5%,32091(32.2%)例患者的HbA1C水平>7.5%。18.3%的患者降糖治疗的强度降低(21.2%的患者比较虚弱,19.4%的患者有多种合并症,17.7%的患者较为健康),这部分患者的血糖水平没有倾斜(占HbA1C<6%的患者的20.6%,占HbA1C水平在6.0%~6.4%的患者的17.3%,占HbA1C水平在6.5%~7.5%的患者的17.7%,占HbA1C水平>7.5%的患者的18.6%)。在排除了26985例使用二甲双胍单药疗法的患者后,也观察到了相似的比例:各HbA1C水平层分别占23.3%、20.4%、20.3%和20%。在HbA1C指标<6%的患者中,22.5%的患者在2008 年2月前治疗强度降低,19.5%的患者在2008 年2月后治疗强度降低(P<0.001)。

结论:在虚弱的患者或有多种并存病患者中,超过四分之三的低HbA1C患者的血糖治疗强度没有降低,甚至在ACCORD试验中提出安全问题后。

原始出处:
McAlister, F. A., et al.Treatment Deintensification Is Uncommon in Adults With Type 2 Diabetes Mellitus: A Retrospective Cohort Study.Circ Cardiovasc Qual Outcomes. 2017 Apr;10(4). pii: e003514. doi: 10.1161/CIRCOUTCOMES.116.003514.

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2015914, encodeId=2c8f2015914e3, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Wed Sep 27 19:06:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938731, encodeId=c3981938e31a5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Feb 11 19:06:00 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590782, encodeId=d8af1590e821a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11574, encryptionId=0c0b115e4cf, topicName=MES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=874617863969, createdName=longqijun254, createdTime=Wed Jul 05 08:06:00 CST 2017, time=2017-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218310, encodeId=0b6c21831018, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Tue Jul 04 00:23:40 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218198, encodeId=1ad021819871, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 03 18:04:01 CST 2017, time=2017-07-03, status=1, ipAttribution=)]
    2017-09-27 Smile2680
  2. [GetPortalCommentsPageByObjectIdResponse(id=2015914, encodeId=2c8f2015914e3, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Wed Sep 27 19:06:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938731, encodeId=c3981938e31a5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Feb 11 19:06:00 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590782, encodeId=d8af1590e821a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11574, encryptionId=0c0b115e4cf, topicName=MES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=874617863969, createdName=longqijun254, createdTime=Wed Jul 05 08:06:00 CST 2017, time=2017-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218310, encodeId=0b6c21831018, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Tue Jul 04 00:23:40 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218198, encodeId=1ad021819871, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 03 18:04:01 CST 2017, time=2017-07-03, status=1, ipAttribution=)]
    2018-02-11 quxin068
  3. [GetPortalCommentsPageByObjectIdResponse(id=2015914, encodeId=2c8f2015914e3, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Wed Sep 27 19:06:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938731, encodeId=c3981938e31a5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Feb 11 19:06:00 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590782, encodeId=d8af1590e821a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11574, encryptionId=0c0b115e4cf, topicName=MES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=874617863969, createdName=longqijun254, createdTime=Wed Jul 05 08:06:00 CST 2017, time=2017-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218310, encodeId=0b6c21831018, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Tue Jul 04 00:23:40 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218198, encodeId=1ad021819871, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 03 18:04:01 CST 2017, time=2017-07-03, status=1, ipAttribution=)]
    2017-07-05 longqijun254
  4. [GetPortalCommentsPageByObjectIdResponse(id=2015914, encodeId=2c8f2015914e3, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Wed Sep 27 19:06:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938731, encodeId=c3981938e31a5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Feb 11 19:06:00 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590782, encodeId=d8af1590e821a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11574, encryptionId=0c0b115e4cf, topicName=MES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=874617863969, createdName=longqijun254, createdTime=Wed Jul 05 08:06:00 CST 2017, time=2017-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218310, encodeId=0b6c21831018, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Tue Jul 04 00:23:40 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218198, encodeId=1ad021819871, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 03 18:04:01 CST 2017, time=2017-07-03, status=1, ipAttribution=)]
    2017-07-04 189****7206

    学习了谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2015914, encodeId=2c8f2015914e3, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Wed Sep 27 19:06:00 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938731, encodeId=c3981938e31a5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2818, encryptionId=1c292818fd, topicName=ASC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Feb 11 19:06:00 CST 2018, time=2018-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590782, encodeId=d8af1590e821a, content=<a href='/topic/show?id=0c0b115e4cf' target=_blank style='color:#2F92EE;'>#MES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11574, encryptionId=0c0b115e4cf, topicName=MES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=874617863969, createdName=longqijun254, createdTime=Wed Jul 05 08:06:00 CST 2017, time=2017-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218310, encodeId=0b6c21831018, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Tue Jul 04 00:23:40 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=218198, encodeId=1ad021819871, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 03 18:04:01 CST 2017, time=2017-07-03, status=1, ipAttribution=)]
    2017-07-03 三生有幸9135

    学习一下谢谢分享

    0

相关威廉亚洲官网

控体重 减肚腩 多吃菜 勤运动 国人逾七成2型糖尿病可预防

北京大学公共卫生学院吕筠教授课题组完成的论文《中国成人中健康生活方式与2型糖尿病的关联研究》近日刊发在《国际流行病学杂志》上。这项研究结果提示,坚持健康生活方式可以显着降低中国人群中的2型糖尿病负担。

Int J Cardiol:代谢综合征和糖尿病对钙化性主动脉瓣狭窄进展的影响!

在该主动脉狭窄患者的前瞻性队列中,没有发现代谢综合征或糖尿病对AS进展的影响。尽管代谢综合征和糖尿病应该积极治疗,但不应影响AS进展。williamhill asia 的研究结果支持这一理论,即如果心血管疾病的危险因素可能在AS发病早期起作用,但它们对进展没有或没有影响。

Diabetes:组蛋白甲基化转移酶MLL1在伤口修复中指导巨噬细胞介导的炎症反应并且其作用在肥胖的2型糖尿病小鼠中发生了改变

巨噬细胞是伤口修复中发炎期萌生和消除的关键。在糖尿病中,巨噬细胞在后期伤口愈合中表现出持续性的炎症表型。最近发现混合谱系白血病蛋白1(MLL1)通过调控NFκB介导的炎症反应相关基因的转录从而调控基因表达。因此,williamhill asia 猜测在伤口修复中MLL1会影响巨噬细胞介导的炎症发应。williamhill asia 利用骨髓特异性Mll1突变体(Mll1f/fLyz2Cre+)探究MLL1在伤口愈合中的功能。与对照相比,Mll1f/fLyz

Environ Inter:科学家指出2型糖尿病的又一重大隐患!

近期,来自莱斯特大学一个跨学科团队的科学家们发现空气污染与2型糖尿病的上升之间存在着密不可分的关系。

人工智能厉害了!能颠覆医疗吗?

人工智能厉害了,今天williamhill asia 来聊聊人工智能与糖尿病这个高大上的话题。未来,人工智能能颠覆糖尿病及其并发症的治疗吗?万众瞩目的围棋界的“人机大战”,现排名世界第一的我国95后棋手柯洁对战人工智能“阿尔法狗”(AlphaGo),最终,柯洁0:3惨败。发布会上柯洁当场洒泪,除了因为失败而伤心外,更多的应该是人类面对如上帝一般存在的人工智能时,满满的感慨和无力感。百度百科上是这样定义人工智能的:人工智能(

Diabetes Metab:糖尿病患者接受GLP1a治疗有何获益?

2017年6月,发表在《Diabetes Metab》的一项有希腊和英国科学家进行的基于人群的开放队列研究,考察了胰高血糖素样肽-1受体激动剂(GLP1a)治疗的糖尿病患者的全因死亡率。